Danvers, MA, United States of America

Samantha Polak

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Abiomed, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Ventricular Support: The Contributions of Samantha Polak

Introduction

Samantha Polak is an accomplished inventor based in Danvers, MA (US). She has made significant contributions to the field of medical technology, particularly in the area of ventricular support for patients undergoing high-risk procedures. Her innovative approach has the potential to improve patient outcomes during critical interventions.

Latest Patents

Samantha Polak holds a patent for "Methods for providing ventricular support for a human patient." This patent describes a method of providing ventricular support during high-risk percutaneous coronary intervention procedures. The method involves inserting a mechanical circulatory support device into the vasculature of a human patient. This device is designed to be movable between a compressed state and an expanded state, allowing for effective delivery into the heart with the aid of a delivery assist device. The operation of this device during a support period has shown a clinically significant arrhythmia adverse event rate of approximately 2.3%.

Career Highlights

Samantha Polak is currently associated with Abiomed, Inc., a company known for its advancements in heart pump technology. Her work at Abiomed has been instrumental in developing innovative solutions that enhance the safety and efficacy of cardiac procedures.

Conclusion

Samantha Polak's contributions to the field of medical technology, particularly through her patent on ventricular support methods, highlight her role as a leading inventor in this critical area. Her work continues to pave the way for advancements that can significantly benefit patients undergoing high-risk cardiac interventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…